Analysis of multiple published datasets in cBioPortal revealed RSAD2 was altered in 2% of the PCa cases although there was no differentiation between advanced PCa and neuroendocrine-specific subtype indicating the need for further analysis. This evidence concerns the gene RSAD2 and posterior cortical atrophy.